AG-881

DRUG2 trials

Sponsors

Agios Pharmaceuticals, Inc.

Conditions

Healthy Male ParticipantsHealthy Participants

Phase 1

A Safety and Pharmacokinetic Study of AG-881 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C] AG-881 and Concomitant Intravenous Microdose of [13C315N3] AG-881

CompletedNCT03960502

Agios Pharmaceuticals, Inc.Healthy Male Participants

Start: 2019-05-16End: 2019-09-07Updated: 2019-10-23

A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults

CompletedNCT04015687

Agios Pharmaceuticals, Inc.Healthy Participants

Start: 2019-07-15End: 2019-10-09Updated: 2019-10-14